Physician
Dubois Regional Medical Center
Dubois Regional Medical Center was paid $18.77M by Medicaid between Jan 2018 and Dec 2024, across 359 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 54% of everything it billed.
33Billing provider infoDUBOIS REGIONAL MEDICAL CENTER
DU BOIS, PA 15801
DU BOIS, PA 15801
33aNPI1144249657assigned 07/18/2006
33bProvider typeEmergency Medicine Physician
28Total paid$18.77M
24GClaims571,657
24DCodes billed359
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Medicine Physician providers in Pennsylvania
Rank by total paid#2 of 1,211
Median peer was paid$19K
This provider vs. median963×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 715 | $30K | |
| 2019 | 8,632 | $58K | |
| 2020 | 45,642 | $1.29M | |
| 2021 | 222,978 | $7.05M | |
| 2022 | 97,305 | $3.35M | |
| 2023 | 109,151 | $3.86M | |
| 2024incomplete | 87,234 | $3.14M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 54% | 188,880 | 158,312 | $10.07M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.3% | 8,768 | 8,317 | $1.00M |
| G0378 | Hospital observation service, per hour | 4.4% | 540 | 499 | $835K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.6% | 8,301 | 7,990 | $667K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.1% | 4,032 | 3,782 | $591K |
| 87631 | 2.4% | 3,055 | 3,024 | $449K | |
| X0621 | 1.5% | 1,380 | 922 | $284K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.2% | 1,735 | 1,718 | $216K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,699 | 1,271 | $163K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 2,847 | 2,628 | $155K |
| X0620 | <1% | 520 | 483 | $153K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 4,210 | 3,971 | $142K |
347 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,615 | $134K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 10,526 | $123K |
| 80053 | Comprehensive metabolic panel | <1% | 11,679 | $119K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 2,582 | $108K |
| 80050 | General health panel | <1% | 2,252 | $104K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 179 | $103K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,629 | $100K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 1,899 | $98K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 570 | $90K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 16,995 | $90K |
| J9312 | Injection, rituximab, 10 mg | <1% | 25 | $85K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 929 | $81K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 263 | $77K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,933 | $71K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 2,435 | $68K |
| T1028 | Assessment of home, physical and family environment, to determine suitability to meet patient's medical needs | <1% | 841 | $63K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 4,953 | $58K |
| 76830 | Ultrasound, transvaginal | <1% | 1,207 | $58K |
| 80061 | Lipid panel | <1% | 4,209 | $56K |
| J2323 | Injection, natalizumab, 1 mg | <1% | 13 | $56K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 270 | $54K |
| G0379 | Direct admission of patient for hospital observation care | <1% | 29 | $53K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,562 | $49K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,142 | $46K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,449 | $46K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 182 | $46K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 272 | $45K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,243 | $45K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 793 | $43K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 555 | $43K |
| 0002A | <1% | 1,035 | $42K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 6,412 | $41K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 505 | $40K |
| 0001A | <1% | 1,178 | $39K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 165 | $38K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,441 | $36K |
| 86003 | <1% | 161 | $35K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,306 | $32K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,305 | $32K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 579 | $31K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,967 | $30K |
| 95811 | <1% | 59 | $30K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 179 | $30K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 986 | $29K |
| 97161 | <1% | 526 | $28K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,747 | $25K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 318 | $25K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 451 | $23K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,045 | $23K |
| 83735 | <1% | 3,757 | $22K | |
| G0008 | Administration of influenza virus vaccine | <1% | 2,356 | $22K |
| 76813 | <1% | 406 | $21K | |
| 96415 | <1% | 453 | $20K | |
| 81001 | <1% | 7,026 | $20K | |
| 84439 | <1% | 2,314 | $19K | |
| 87480 | <1% | 791 | $19K | |
| 87660 | <1% | 778 | $18K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 405 | $18K |
| T1001 | Nursing assessment / evaluation | <1% | 113 | $18K |
| 84484 | <1% | 2,346 | $18K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,654 | $17K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 299 | $16K |
| 80081 | <1% | 181 | $16K | |
| 80076 | <1% | 1,891 | $16K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 398 | $16K |
| 71250 | <1% | 253 | $15K | |
| 82607 | <1% | 1,255 | $15K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 36 | $15K |
| 86618 | <1% | 616 | $15K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 397 | $14K |
| 93971 | <1% | 200 | $14K | |
| 76641 | <1% | 214 | $13K | |
| 97162 | <1% | 217 | $13K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,963 | $13K |
| 77412 | <1% | 261 | $12K | |
| 73564 | <1% | 520 | $12K | |
| 96367 | <1% | 620 | $12K | |
| 82784 | <1% | 369 | $12K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 552 | $11K |
| G9016 | Smoking cessation counseling, individual, in the absence of or in addition to any other evaluation and management service, per session (6-10 minutes) [demo project code only] | <1% | 728 | $11K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 251 | $11K |
| 99501 | <1% | 147 | $11K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 434 | $11K |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 1,581 | $11K |
| 84702 | <1% | 603 | $10K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 178 | $10K |
| 82570 | <1% | 1,480 | $10K | |
| 73610 | <1% | 545 | $10K | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 509 | $10K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 13 | $10K |
| 76536 | <1% | 202 | $10K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,022 | $10K |
| 87081 | <1% | 1,635 | $9K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 255 | $9K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 1,140 | $9K |
| 82746 | <1% | 779 | $9K | |
| 82728 | <1% | 795 | $9K | |
| 82043 | <1% | 1,149 | $9K | |
| 73221 | <1% | 40 | $8K | |
| 20610 | <1% | 787 | $8K | |
| 84703 | <1% | 773 | $8K | |
| 85027 | <1% | 1,272 | $8K | |
| 72110 | <1% | 364 | $8K | |
| 87186 | <1% | 995 | $8K | |
| 87077 | <1% | 1,049 | $8K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 689 | $7K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 226 | $7K |
| 86038 | <1% | 499 | $7K | |
| 83690 | <1% | 1,628 | $7K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 787 | $7K |
| 73630 | <1% | 610 | $7K | |
| 94729 | <1% | 234 | $7K | |
| 86235 | <1% | 93 | $7K | |
| 87510 | <1% | 756 | $7K | |
| 81025 | <1% | 1,393 | $7K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 309 | $7K |
| 84153 | <1% | 293 | $7K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 264 | $7K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 108 | $7K |
| 83880 | <1% | 300 | $7K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 274 | $7K |
| 77065 | Tomosynthesis, mammo | <1% | 105 | $7K |
| 86480 | <1% | 96 | $7K | |
| 73030 | <1% | 410 | $7K | |
| 72141 | <1% | 34 | $7K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 17 | $7K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 60 | $7K |
| 94726 | <1% | 232 | $6K | |
| 83970 | <1% | 173 | $6K | |
| 81003 | <1% | 2,409 | $6K | |
| 86617 | <1% | 158 | $6K | |
| 84460 | <1% | 903 | $6K | |
| 90686 | <1% | 1,321 | $6K | |
| 84450 | <1% | 879 | $6K | |
| 85730 | <1% | 1,113 | $6K | |
| 90715 | <1% | 968 | $6K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 1,443 | $6K |
| 83540 | <1% | 702 | $5K | |
| Q9956 | Injection, octafluoropropane microspheres, per ml | <1% | 95 | $5K |
| 73502 | <1% | 276 | $5K | |
| 82565 | <1% | 904 | $5K | |
| 85610 | <1% | 1,751 | $5K | |
| 87070 | <1% | 770 | $5K | |
| 85652 | <1% | 1,835 | $5K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 141 | $5K |
| 87481 | <1% | 127 | $5K | |
| 73130 | <1% | 388 | $5K | |
| 87797 | <1% | 190 | $5K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 251 | $4K |
| 87040 | <1% | 347 | $4K | |
| 95806 | <1% | 65 | $4K | |
| 86140 | <1% | 1,530 | $4K | |
| 73110 | <1% | 361 | $4K | |
| 86334 | <1% | 155 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 15 | $4K |
| 86787 | <1% | 211 | $4K | |
| 93017 | <1% | 106 | $4K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 460 | $4K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 55 | $4K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 12 | $4K |
| 85379 | <1% | 408 | $4K | |
| 80320 | <1% | 331 | $4K | |
| 76942 | <1% | 121 | $4K | |
| 83615 | <1% | 569 | $4K | |
| 94060 | <1% | 336 | $3K | |
| 84550 | <1% | 671 | $3K | |
| 82805 | <1% | 118 | $3K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 776 | $3K |
| 77066 | Tomosynthesis, mammo | <1% | 39 | $3K |
| 76770 | <1% | 80 | $3K | |
| 86160 | <1% | 94 | $3K | |
| 77336 | <1% | 61 | $3K | |
| 93970 | <1% | 38 | $3K | |
| 84100 | <1% | 596 | $3K | |
| A0425 | Ground mileage, per statute mile | <1% | 1,281 | $3K |
| 86850 | <1% | 472 | $3K | |
| 70498 | <1% | 25 | $3K | |
| 83605 | <1% | 532 | $3K | |
| 86431 | <1% | 355 | $3K | |
| 76642 | <1% | 71 | $3K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 16 | $3K |
| 76801 | <1% | 58 | $3K | |
| 82785 | <1% | 153 | $3K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,205 | $3K |
| 74018 | <1% | 199 | $3K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 190 | $2K |
| 86200 | <1% | 157 | $2K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 336 | $2K |
| 83550 | <1% | 481 | $2K | |
| 95886 | <1% | 41 | $2K | |
| 72050 | <1% | 91 | $2K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 41 | $2K |
| 77334 | <1% | 15 | $2K | |
| 83721 | <1% | 188 | $2K | |
| 82550 | <1% | 325 | $2K | |
| 87340 | <1% | 149 | $2K | |
| 86592 | <1% | 474 | $2K | |
| 87522 | Neg quan hep c or qual rna | <1% | 46 | $2K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 225 | $2K |
| 82950 | <1% | 246 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,242 | $2K |
| 84156 | <1% | 417 | $2K | |
| 80305 | <1% | 172 | $2K | |
| 86900 | <1% | 513 | $2K | |
| 84146 | <1% | 58 | $2K | |
| 77080 | <1% | 28 | $2K | |
| 86901 | <1% | 509 | $2K | |
| 86225 | <1% | 96 | $1K | |
| 73080 | <1% | 126 | $1K | |
| 82247 | <1% | 222 | $1K | |
| 70220 | <1% | 64 | $1K | |
| 82248 | <1% | 207 | $1K | |
| 99173 | <1% | 224 | $1K | |
| 92133 | <1% | 153 | $1K | |
| 93975 | <1% | 12 | $1K | |
| 97165 | <1% | 46 | $1K | |
| 76820 | <1% | 58 | $1K | |
| 82150 | <1% | 251 | $1K | |
| 87102 | <1% | 140 | $1K | |
| 84403 | <1% | 43 | $1K | |
| 73562 | <1% | 61 | $1K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 32 | $1K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 257 | $1K |
| 72072 | <1% | 55 | $1K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 13 | $1K |
| 86800 | <1% | 65 | $1K | |
| 84520 | <1% | 238 | $1K | |
| 96376 | <1% | 627 | $1K | |
| 84480 | <1% | 126 | $1K | |
| 96523 | <1% | 59 | $989.58 | |
| 73590 | <1% | 61 | $986.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 900 | $953.69 |
| 10005 | <1% | 14 | $919.64 | |
| 11981 | <1% | 12 | $916.30 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 12 | $865.60 |
| 86403 | <1% | 53 | $774.50 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,894 | $758.20 |
| 84436 | <1% | 81 | $737.31 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 298 | $735.50 |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,834 | $700.13 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,107 | $645.57 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 3,222 | $642.45 |
| X0592 | <1% | 14 | $616.00 | |
| 84165 | <1% | 47 | $607.04 | |
| 74022 | <1% | 25 | $600.00 | |
| 76775 | <1% | 13 | $592.90 | |
| 88342 | <1% | 14 | $573.95 | |
| 87501 | <1% | 15 | $566.26 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,174 | $543.24 |
| 87641 | <1% | 26 | $536.33 | |
| 86255 | <1% | 27 | $523.48 | |
| 73523 | <1% | 15 | $521.25 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 12 | $521.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,535 | $501.36 |
| 86039 | <1% | 29 | $477.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 410 | $471.93 |
| 86376 | <1% | 59 | $470.61 | |
| 93226 | <1% | 13 | $437.40 | |
| 82310 | <1% | 72 | $421.57 | |
| 80329 | <1% | 51 | $414.19 | |
| 95816 | <1% | 29 | $411.45 | |
| 92551 | <1% | 49 | $396.00 | |
| 82040 | <1% | 136 | $384.44 | |
| 3044F | <1% | 3,178 | $378.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,618 | $360.92 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 650 | $345.90 |
| 83516 | <1% | 157 | $345.78 | |
| 87046 | <1% | 26 | $332.96 | |
| 77417 | <1% | 22 | $330.12 | |
| 87209 | <1% | 16 | $309.40 | |
| 84075 | <1% | 55 | $300.79 | |
| 82140 | <1% | 77 | $299.50 | |
| 92134 | <1% | 31 | $297.12 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 209 | $293.65 |
| 70030 | <1% | 15 | $259.43 | |
| 86706 | <1% | 15 | $246.50 | |
| 3052F | <1% | 604 | $228.37 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 55 | $223.24 |
| 73120 | <1% | 16 | $220.65 | |
| 3046F | <1% | 1,147 | $220.00 | |
| 72100 | <1% | 14 | $219.50 | |
| 72202 | <1% | 14 | $217.80 | |
| 83001 | <1% | 13 | $211.75 | |
| 86812 | <1% | 18 | $211.20 | |
| 90688 | <1% | 19 | $209.00 | |
| 81508 | <1% | 53 | $206.64 | |
| 93225 | <1% | 13 | $200.80 | |
| 84163 | <1% | 13 | $196.24 | |
| 96127 | <1% | 48 | $193.44 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 24 | $184.56 |
| 87045 | <1% | 26 | $182.16 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,162 | $179.31 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 4,771 | $178.86 |
| 73552 | <1% | 12 | $168.84 | |
| 84112 | <1% | 30 | $161.28 | |
| 82533 | <1% | 12 | $158.40 | |
| 3051F | <1% | 1,111 | $153.00 | |
| 88304 | <1% | 31 | $143.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 12 | $142.20 |
| 36600 | <1% | 16 | $141.70 | |
| 80178 | <1% | 18 | $140.80 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 453 | $140.58 |
| 86580 | <1% | 27 | $139.15 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 915 | $126.52 |
| 87177 | <1% | 16 | $115.50 | |
| 96160 | <1% | 33 | $111.07 | |
| 83520 | <1% | 29 | $99.00 | |
| 87581 | <1% | 28 | $95.76 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 307 | $91.14 |
| 87205 | <1% | 46 | $88.65 | |
| J2704 | Injection, propofol, 10 mg | <1% | 259 | $76.70 |
| A6258 | Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing | <1% | 26 | $66.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 54 | $66.00 |
| 82009 | <1% | 18 | $58.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 16 | $51.28 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 247 | $43.00 |
| 90662 | <1% | 53 | $40.34 | |
| 88108 | <1% | 16 | $33.15 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 43 | $21.55 |
| A4248 | Chlorhexidine containing antiseptic, 1 ml | <1% | 425 | $17.23 |
| A9270 | Non-covered item or service | <1% | 321 | $16.50 |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 86 | $15.26 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 331 | $14.98 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 761 | $0.06 |
| 3078F | 0% | 25,752 | $0.00 | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 0% | 267 | $0.00 |
| 3077F | 0% | 4,638 | $0.00 | |
| 81513 | 0% | 82 | $0.00 | |
| 88173 | 0% | 16 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 918 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 44 | $0.00 |
| 0353U | 0% | 80 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 49 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 12 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 20 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 12 | $0.00 |
| A4212 | Non-coring needle or stylet with or without catheter | 0% | 19 | $0.00 |
| 3079F | 0% | 15,022 | $0.00 | |
| 3080F | 0% | 3,281 | $0.00 | |
| 3074F | 0% | 34,878 | $0.00 | |
| 3075F | 0% | 5,939 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 910 | $0.00 |
| C2618 | Probe/needle, cryoablation | 0% | 62 | $0.00 |
| J9045 | Injection, carboplatin, 50 mg | 0% | 16 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 270 | $0.00 |
| 90656 | 0% | 82 | $0.00 | |
| 90677 | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHNEIDER, HEATHER (CFO)
Parent organizationPENN HIGHLANDS HEALTHCARE
| Provider | Location | Paid |
|---|---|---|
| Dubois Regional Medical Center | Brookville, PA | $336K |
| Highlands Hospital and Health Center | Connellsville, PA | $179K |
| Dubois Regional Medical Center | Du Bois, PA | $140K |
| Dubois Regional Medical Center | Du Bois, PA | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.